Intrinsic Value of S&P & Nasdaq Contact Us

Protagenic Therapeutics, Inc. PTIXW NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
11/100
0/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Protagenic Therapeutics, Inc. (PTIXW) has 20 known insider and institutional holders on record. The largest holder is Larner Drew with 7,500,000 shares. Other notable holders include Regenstein Barry and Trinad Capital Master Fund Ltd..

PTIXW Insider Ownership

Top Holder
Larner Drew
7,500,000 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Larner Drew Director 7,500,000 2007-03-06
100%
2 Regenstein Barry Director 7,500,000 2007-03-07
100%
3 Trinad Capital Master Fund Ltd. 10 Percent Owner 2,349,370 2010-01-07
31%
4 Kier Isaac Director 1,785,085 2006-10-26
24%
5 Ekizian Gregory Director 645,000 2016-06-22
9%
6 Schwartz Jeffrey A Chief Executive Officer 500,000 2010-01-29
7%
7 Brilliant Digital Entertainment Inc 10 Percent Owner 360,345 2011-06-02
5%
8 Armen Garo H 10 Percent Owner, Officer: Executive Chairman 300,000 2020-02-26
4%
9 Katz Burton Chief Executive Officer 300,000 2008-08-07
4%
10 Plotts Thomas Chief Financial Officer 250,000 2010-07-02
3%
11 Zaref Andrew Chief Financial Officer 200,000 2008-07-29
3%
12 Barrage Khalil Director 180,000 2021-06-01
2%
13 Stein Robert Benjamin Director 150,000 2020-02-26
2%
14 Buell Jennifer Director 145,000 2020-07-21
2%
15 Corvese Brian Director 120,000 2020-02-26
2%
16 Silverman Joshua Director 120,000 2020-02-26
2%
17 Musci Raymond Exec VP, Corporate Development 109,155 2010-12-17
1%
18 Chazen Jerome A Director 64,159 2010-09-30
1%
19 Banon Sid Officer 59,503 2006-10-27
1%
20 Legator Allan CFO and Secretary 50,000 2008-01-31
1%

No ownership data available for PTIXW.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message